|

AUCD Community Inclusion

AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

Learn More
|

AUCD Maternal and Child Health Engagement

AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

Learn More
|

AUCD Public Health

AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

Learn More
|

AUCD Emerging Leaders Community

AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.

Learn More

Donate

Product

LEND: Reevaluation of Sodium Thiosulfate Otoprotection Using the Consensus International Society of Pediatric Oncology Ototoxicity Scale: A report from the Children's Oncology Group Study ACCL0431

Center:

OR-Oregon Institute on Development & Disability, UCEDD/LEND

Fiscal Year:

2023

Contact Information:

Kristin Knight
[email protected]
503-494-2061

Product Description:

Data from clinical trial ACCL0431 was re-analyzed using the consensus Society of International Paediatric Oncology (SIOP) Ototoxicity Scale to facilitate comparison of results with future studies. STS reduced the incidence of moderate to severe cisplatin induced hearing loss and delayed the onset of moderate to severe hearing loss.

Keyword(s):

hearing loss, cisplatin, ototoxicity, otoprotection

Product/Publication Type(s):

Peer-reviewed publications in scholarly journals submitted

Target Audience:

Professionals, Students

Alternative Format:

Electronic (disc, CD, 508 compliant web posting)

To Obtain Copies (URL or Email):

COVID-19 Related Data:

N/A

1100 Wayne Avenue, Suite 1000 Silver Spring, MD 20910